[1]
S. Fagiuoli, M. Ruggeri, F. Aragao, and R. Blissett, “The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment”, Grhta, vol. 8, no. 1, pp. 58–66, Apr. 2021.